scholarly journals HMG-CoA Reductase Inhibitory Activity of Leaf-associated Fungi

2020 ◽  
Vol 54 (5) ◽  
Author(s):  
Roland M. Hipol ◽  
Regina B. Hipol ◽  
Mavis Colleen P. Fabian ◽  
Joseph S. Sasotona ◽  
Christine C. Hernandez

Background. Cholesterol is an important biomolecule for cells. However, because of certain lifestyle, theamount of cholesterol can increase beyond what our bodies can consume. Increased intake may result in theaccumulation of cholesterol in the blood leading to atherosclerosis that can lead to congestive heart failure.With the use of statins, cholesterol levels are reduced therefore lowering the risk for this disease. It does so byinhibiting the hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase, the first committed enzyme in cholesterolbiosynthesis. In light of the increasing cases of hypercholesterolemia, there is a need to discover novel classesof HMG-CoA inhibitors. Objective. The primary objective of this study was to screen extracts of leaf-associated fungi for their capacityto inhibit hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase, the first committed enzyme in cholesterolbiosynthesis. Methods. Eight (8) plants were sampled for the fungal epiphytes and endophytes on their leaves. The fungalisolates were identified by sequencing the internal transcribed region (ITS) of the 18S rDNA. All fungal isolates werecultured in 20 flasks containing 300 mL potato dextrose broth at 30°C for 14 days. The culture broths were thensubjected to reduction in volume using a rotary evaporator. HMG-CoA reductase inhibition assay was carried outusing the ethyl acetate extracts from the culture broths. Reagent grade pravastatin was used as the positive control. Results. There were a total of sixty-six (66) fungal taxa that were tested for their capacity to inhibit the enzymeHMG-CoA reductase. Of the 50 that tested positive, there were 25 families represented and 5 isolates were ofuncertain status taxonomically (incertae sedis). There were also nine classes that were represented and the class withthe most number of isolates was Sordariomycetes. The highest percentage inhibition was observed in Pestalotiopsislespedezae with 65.01 % inhibition. The other fungi with notable inhibitory activities were Colletotrichum cymbidiicola(64.16%) and Schizophyllum commune (57.85%). Conclusions. This study may be the first report of production of HMG-CoA reductase inhibitors in the genusColletotrichum and in the other leaf-associated fungal taxa that tested positive for HMG-CoA reductase inhibition.It is therefore very promising that a novel statin compound, or even a new class of substances with antihypercholesterolemic bioactivity may be discovered from these leaf-associated fungal isolates. The crude extractsof these fungi are prime candidates for downstream fractionation for the subsequent isolation and structureelucidation of the bioactive compound.

1984 ◽  
Vol 48 (11) ◽  
pp. 2745-2751
Author(s):  
Hirosuke OKU ◽  
Akira MORITA ◽  
Takashi IDE ◽  
Michihiro SUGANO

2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
Janet P.-C. Wong ◽  
Sumi Wijaya ◽  
Kang-Nee Ting ◽  
Christophe Wiart ◽  
Kamarul’Ain Mustafa ◽  
...  

If left untreated, hypercholesterolaemia can lead to atherosclerosis, given time. Plants from the Fabaceae family have shown the ability to significantly suppress atherosclerosis progression. We selected four extracts fromPithecellobium ellipticum, from the Fabaceae family, to be screened in a 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) assay. The ethanol extract, at a concentration of 500 μg/mL, exhibited superior inhibition properties over the other extracts by demonstrating 80.9% inhibition, while 0.223 μg/mL of pravastatin (control) showed 78.1% inhibition towards enzymatic activity. These findings led to the fractionation of the ethanol extract using ethyl acetate : methanol (95 : 5), gradually increasing polarity and produced seven fractions (1A to 7A). Fraction 7A at 150 μg/mL emerged as being the most promising bioactive fraction with 78.7% inhibition. FRAP, beta carotene, and DPPH assays supported the findings from the ethanol extract as it exhibited good overall antioxidant activity. The antioxidant properties have been said to reduce free radicals that are able to oxidize lipoproteins which are the cause of atherosclerosis. Phytochemical screenings revealed the presence of terpenoid, steroid, flavonoid, and phenolic compounds as the responsible group of compound(s), working individually or synergistically, within the extract to prevent binding of HMG-CoA to HMG-CoA reductase.


Author(s):  
Jeffrey A. Cohen ◽  
Justin J. Mowchun ◽  
Victoria H. Lawson ◽  
Nathaniel M. Robbins

Statin myopathy can occur at anytime during use. This chapter discusses an approach to diagnosis, and emphasizes management considerations, including awareness of statin metabolism by the cytochrome P-450 system. A statin must be discontinued in any patient with evidence of myopathy or myalgias. A muscle biopsy should be done in cases that do not improve clinically or by creatine kinase level. It is important to note that there are cases of apparent statin myopathy which transform into a chronic autoimmune inflammatory myopathy. Antibodies to hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase have recently been identified in the majority of patients with autoimmune statin myopathy and this test may give further weight to treat with immunotherapy.


Sign in / Sign up

Export Citation Format

Share Document